Yubo International Biotech Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
For the six months, sales was USD 0.023183 million compared to USD 0.8138 million a year ago. Net loss was USD 1.07 million compared to USD 0.808683 million a year ago. Basic loss per share from continuing operations was USD 0.01 compared to USD 0.01 a year ago.